GSK extension
-
News
GSK acquires 36.5% of the Consumer Health joint venture from Novartis
Rome, 28 March – RIF Day – Novartis has reached an agreement with GlaxoSmithKline (Gsk) to sell them its 36.5%…
Leggi » -
News
RSU GSK elections. Filctem in the majority, Femca on the rise
Thursday 1 February, at the end of the three days that Gsk vaccines employees, working at the Siena and Rosia sites,…
Leggi » -
News
Silent revolution in GSK, the new CEO replaces 40 percent of the management
Emma Walmsley, new CEO of GlaxoSmithKline, replaced 50 top managers in a few months, 40% of the highest…
Leggi » -
News
The growth of Italy and the case of the pharmaceutical industry
In Italy, growth is accelerating. Istat data say so in a preliminary estimate of the second quarter of 2017. The Product…
Leggi » -
News
British GSK to cut 320 jobs in the UK. Verona closes: 300 workers at risk in Italy
It is a consequence of the sale of the brands Horlicks 'and 'MaxiNutrition' EUROPA PRESS – 07/19/2017 – el Economista The pharmaceutical house…
Leggi » -
News
Filctem Siena: what future for Gsk?
“Just over a year after GSK announced its intention to invest around 600 million in Sienese sites,…
Leggi » -
News
Emma Walmsley is the new Chief Executive Officer of GSK
Emma Walmsley has been appointed Chief Executive Officer of GlaxoSmithKline plc effective 1 April 2017. Emma has joined GSK…
Leggi » -
News
Emma Walmsley new CEO of GlaxoSmithKline
Surprise at GlaxoSmithKline with the appointment of Emma Walmsley, an internal, as CEO of the pharmaceutical company. The nomination is…
Leggi » -
News
Parma. Gsk, Filctem: risk of strong employment contraction
Sale agreement by GSK (GlaxoSmithKline) of the anesthetics portfolio in Aspen, with the relocation of production. Strong concern, above all…
Leggi » -
News
Meningitis, GSK launches 'Take 5 for Meningitis' awareness campaign
Meningococcal meningitis is a life-threatening disease caused by the bacterium Neisseria meningitidis, and consists of severe inflammation…
Leggi »